[ACRX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -109.55%
YoY- 19.40%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 253 0 252 507 570 442 2 2442.39%
PBT -4,425 64 -7,485 -6,739 70,666 -8,674 -7,917 -32.21%
Tax 3 -5,273 -1 11 3 -321 467 -96.57%
NP -4,371 5,337 -7,484 -6,750 70,663 -8,353 -7,917 -32.77%
Tax Rate - 8,239.06% - - -0.00% - - -
Total Cost 4,624 -5,337 7,736 7,257 -70,093 8,795 7,919 -30.20%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -1,727.67 0.00 -2,969.84 -1,331.36 12,397.02 -1,889.82 -395,850.00 -97.35%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.40 0.49 -1.01 -0.91 9.60 -1.15 -1.24 -53.06%
EPS Diluted -0.40 0.49 -1.01 -0.91 9.60 -1.15 -1.24 -53.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.